We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -2.62901655307 | 10.27 | 10.93 | 10.02 | 3673091 | 10.58910206 | CS |
4 | -1.7 | -14.5299145299 | 11.7 | 11.82 | 10.02 | 2792050 | 10.96380209 | CS |
12 | -2.43 | -19.5494770716 | 12.43 | 14.03 | 10.02 | 3117964 | 12.17032625 | CS |
26 | -0.9 | -8.25688073394 | 10.9 | 14.57 | 9.7 | 3067164 | 12.15884776 | CS |
52 | -1.48 | -12.8919860627 | 11.48 | 14.57 | 9.7 | 2791691 | 12.22539813 | CS |
156 | -0.05 | -0.497512437811 | 10.05 | 14.57 | 5.91 | 2699286 | 10.9263638 | CS |
260 | -3.3 | -24.8120300752 | 13.3 | 25.39 | 5.91 | 2730867 | 11.60429333 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions